Pediatric Cardiology

, Volume 26, Issue 3, pp 234–240 | Cite as

Patent Foramen Ovale and Left Atrial Appendage: New Devices and Methods for Closure

  • R. Hein
  • Y. Bayard
  • M. Taaffe
  • F. Büscheck
  • S. Ostermayer
  • K. Billinger
  • M. Reschke
  • T. Trepels
  • H. Lißmann-Jensen
  • K. Lang
  • A. Römer
  • N. Wilson
  • H. Sievert
Article

Abstract

Transcatheter closure of atrial septal defects (ASDs) has become a routine procedure in many countries of the world. It spares many patients cardiac surgery and has proven efficacy in long-term studies. Device improvements have resulted in a continuous reduction of complications and of residual shunt frequency. ASD closure devices are also used for transcatheter closure of patent foramen ovale (PFO) for prevention of paradoxical embolism. In the past few years, there has been increasing interest in developing devices specifically designed for PFO closure. Although transcatheter closure of ASDs is well established, interventional closure of the left atrial appendage is in its development stage. Closure of the left atrial appendage is designed to reduce the risk of stroke in patients with atrial fibrillation in whom anticoagulation with Warfarin-type drugs is contraindicated. This article describes the latest developments in catheter closure of PFO and the left atrial appendage.

Key words

Embolism Atrial septal defect Patent foramen ovale Left atrial appendage Device review 

References

  1. 1.
    Comess, KA, DeRook, FA, Beach, KW,  et al. 1994Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke riskJ Am Coll Cardiol2315981603PubMedGoogle Scholar
  2. 2.
    Das, GS, Voss, G, Jarvis, G 1993Experimental atrial septal defect closure with a new, transcatheter, self-centering deviceCirculation8817541764PubMedGoogle Scholar
  3. 3.
    Homma, S Sacco, RL Di Tullio, MR PFO in Cryptogenic Stroke Study (PICCS) Investigators et al. 2002Effect of medical treatment in stroke patients with patent foramen ovale in Cryptogenic Stroke StudyCirculation10526252632CrossRefPubMedGoogle Scholar
  4. 4.
    King, TD, Mills, NL 1976Secundum atrial septal defects: nonoperative closure during cardiac catheterisationJ Am Med Assoc23525062509CrossRefGoogle Scholar
  5. 5.
    Krumsdorf, U, Ostermayer, S, Sievert, H,  et al. 2004Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patientsJ Am Coll Cardiol43302309CrossRefPubMedGoogle Scholar
  6. 6.
    Lock, JE, Block, PC, McKay, RG 1988Transcatheter closure of ventricular septal defectsCirculation78361368PubMedGoogle Scholar
  7. 7.
    Mas, J Arquizan, C Lamy, C Patent Foramen Ovale and Atrial Septal Aneurysm Study Group2001Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or bothN Engl J Med34517401746CrossRefPubMedGoogle Scholar
  8. 8.
    Mas, J Zuber, M Patent Foramen Ovale and Atrial Septal Aneurysm Study Group1995Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or both and cryptogenic stroke or transient ischemic attackAm Heart J13010831088CrossRefPubMedGoogle Scholar
  9. 9.
    Meier, B, Palacios, I, Windecker, S,  et al. 2003Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillationCathet Cardiovasc Interv60417422CrossRefGoogle Scholar
  10. 10.
    Rao, PS, Berger, F, Rey, C 2000Results of transvenous occlusion of secundum atrial septal defects with fourth generation buttoneddevice: comparison with first, second and third generation devicesJ Am Cardiol35583592CrossRefGoogle Scholar
  11. 11.
    Rao, PS, Sideris, EB, Hausdorf, G 1994International experience with secundum atrial septal defect occlusion by the buttoned deviceAm Heart J12810221035CrossRefPubMedGoogle Scholar
  12. 12.
    Rashkind, WJ 1983Transcatheter treatment of congenital heart diseaseCirculation67711716PubMedGoogle Scholar
  13. 13.
    Ryan, C, Opalsk, S, Wright, J 1998

    Structural considerations in the development of the CardioSeal septal occluder

    Imai, YMomma, K eds. Proceedings of the Second World Congress of Pediatric Cardiology and Cardiac SurgeryFuturaArmonk, NY191193
    Google Scholar
  14. 14.
    Sievert, H, Babic, UU, Hausdorf, G 1998Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial)Am J Cardiol8214051413CrossRefPubMedGoogle Scholar
  15. 15.
    Sievert, H, Lesh, MD, Trepels, T,  et al. 2002Percutaneus left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experienceCirculation10518871889CrossRefPubMedGoogle Scholar
  16. 16.
    Zahn, EM, Wilson, N, Cutright, W,  et al. 2001Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion systemCirculation104711716PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • R. Hein
    • 1
  • Y. Bayard
    • 1
  • M. Taaffe
    • 1
  • F. Büscheck
    • 1
  • S. Ostermayer
    • 1
  • K. Billinger
    • 1
  • M. Reschke
    • 1
  • T. Trepels
    • 1
  • H. Lißmann-Jensen
    • 1
  • K. Lang
    • 1
  • A. Römer
    • 1
  • N. Wilson
    • 1
  • H. Sievert
    • 1
  1. 1.CardioVascular Center FrankfurtSankt KatharinenGermany

Personalised recommendations